VCYT insider trading
See Veracyte (VCYT) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| Holstein Jens | Director | Sell | Sep 24, 2026 | Oct 28, 2026 | 7,500 | $47.00 | $352.50K | Filing |
| Holstein Jens | Director | Sell | Oct 27, 2026 | Oct 28, 2026 | 7,500 | $50.00 | $375.00K | Filing |
| EASTHAM KARIN | Director | Sell | Oct 27, 2026 | Oct 28, 2026 | 14,850 | $50.00 | $742.57K | Filing |
| Bhanji Muna | Director | Sell | Oct 19, 2026 | Oct 20, 2026 | 1,864 | $43.70 | $81.46K | Filing |
| Leite John | Global Chief Commercial Off | Sell | Sep 21, 2026 | Sep 22, 2026 | 4,015 | $40.00 | $160.60K | Filing |
| Holstein Jens | Director | Sell | Sep 14, 2026 | Sep 16, 2026 | 5,000 | $40.95 | $204.75K | Filing |
| McGuire Annie | EVP, General Counsel | Sell | Sep 4, 2026 | Sep 4, 2026 | 2,154 | $42.79 | $92.17K | Filing |
| McGuire Annie | EVP, General Counsel | Sell | Sep 4, 2026 | Sep 4, 2026 | 1,100 | $43.67 | $48.04K | Filing |
| Chambers Rebecca | Chief Financial Officer | Sell | Sep 4, 2026 | Sep 4, 2026 | 2,477 | $42.81 | $106.04K | Filing |
| Chambers Rebecca | Chief Financial Officer | Sell | Sep 4, 2026 | Sep 4, 2026 | 1,175 | $43.71 | $51.36K | Filing |
| Febbo Phillip G. | Chief Scientific & Med Officer | Sell | Sep 4, 2026 | Sep 4, 2026 | 10,405 | $42.89 | $446.27K | Filing |
| Febbo Phillip G. | Chief Scientific & Med Officer | Sell | Sep 4, 2026 | Sep 4, 2026 | 2,705 | $43.66 | $118.10K | Filing |
| Bhanji Muna | Director | Sell | Sep 1, 2026 | Sep 3, 2026 | 1,864 | $42.97 | $80.10K | Filing |
| EASTHAM KARIN | Director | Sell | Jun 18, 2026 | Jun 22, 2026 | 3,200 | $52.78 | $168.91K | Filing |
| EASTHAM KARIN | Director | Sell | Jun 18, 2026 | Jun 22, 2026 | 529 | $53.55 | $28.33K | Filing |
| McGuire Annie | EVP, General Counsel | Sell | Jun 4, 2026 | Jun 4, 2026 | 1,400 | $49.31 | $69.03K | Filing |
| McGuire Annie | EVP, General Counsel | Sell | Jun 4, 2026 | Jun 4, 2026 | 1,776 | $50.12 | $89.01K | Filing |
| Chambers Rebecca | Chief Financial Officer | Sell | Jun 4, 2026 | Jun 4, 2026 | 1,600 | $49.28 | $78.85K | Filing |
| Chambers Rebecca | Chief Financial Officer | Sell | Jun 4, 2026 | Jun 4, 2026 | 1,961 | $50.09 | $98.23K | Filing |
| Stapley Marc | Chief Executive Officer, Director | Sell | Jun 4, 2026 | Jun 4, 2026 | 138,051 | $50.12 | $6.92M | Filing |
| Leite John | Global Chief Commercial Off | Sell | Jun 4, 2026 | Jun 4, 2026 | 13,975 | $50.07 | $699.73K | Filing |
| Wygant Jonathan | VP, Chief Accounting Officer | Sell | May 22, 2026 | May 27, 2026 | 24,000 | $45.40 | $1.09M | Filing |
| EPSTEIN ROBERT S | Director | Sell | May 20, 2026 | May 22, 2026 | 10,000 | $44.01 | $440.13K | Filing |
| McGuire Annie | SVP, General Counsel | Sell | May 6, 2026 | May 8, 2026 | 5,102 | $38.05 | $194.13K | Filing |